|
| |
|
|
2008 iBio
(May 18-22, 2008,Hangzhou,China)
|
| |
|
|
| |
|
|
|
|
|
|
|
IDDST 2008
Oct.18-22,2008
Beijing, China |
|
CEMD-2008
Oct.22-28, 2008,
Beijing & Xi'an, China
|
|
|
RSWC 2008
(Oct.23-25, 2008, Beijing, China)
|
|
WCV 2008
( Dec.1-5, 2008, Guangzhou, China) |
|
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China) |
|
|
|
|
|
|
|
|
Full Program |
Theme: From Concept to Market |
| |
Time: April 22-24, 2008
Place: Shenzhen Convention & Exhibition Center (SCEC), China |
| |
| The scientific program for the conference is under development by selecting hot topics for oral presentations and technological summary for posters. Poster sessions will be held through the whole congress. |
| |
April 21, 2008 (Monday)
8:00-22:00 Registration at Hotel Lobby of Grand View Hotel
April 22, 2008 (Tuesday)
8:00-20:00 Registration at Hotel Lobby of Grand View Hotel
Opening Ceremony and Keynote Forum |
| |
Time |
Activities |
8:15-8:30 |
Group Photo in front of shenzhen convention & Exhibition Center |
9:00-9:05 |
Chair’s Opening Remarks
Dr. Ling CHEN, Director General, Principle Investigator of Guangzhou Institute of Biomedicine and Health, CAS (GIBH, CAS) |
9:05-9:10 |
Hosting Organization Address |
9:10-9:45 |
VIP & Sponsors Addresses
Leader of Local Municipal Government (invited)
Nobel Prize Laureate in Medicine/Chemistry (under Coordination)
Representative of Leading Scientist from Domestic Protein Society
Executive Chair from Congress Organizing Committee
Executive Representative of international Academic/Industrial Organization
|
9:45-11:45 |
Keynote Forum:
Chair: Dr. Wen L. Zheng, Chair, South Genomics Research Center, Professor, South Medical University Guangzhou, China
| 09:45-10:15 |
Title: Evolution of Studies of Protein Structure and Protein Folding Pathways by Experiment and Theory
Dr. Harold A. Scheraga, Todd Professor of Chemistry, Emeritus, Baker Laboratory of Chemistry and Chemical Biology, Cornell University, USA |
| 10:15-10:45 |
Title: Mechanism and Inhibition of Collagenolytic Matrix Metalloproteinases
Dr. Gregg B. Fields, Professor, Department of Biomedical Science, Florida Atlantic University, President Elect of American Peptide Society (APS), USA |
| 10:45-11:15 |
Title: Post-translational Modifications and the Dynamics of the Interactome
Dr. Marc Wilkins, Professor, University of New South Wales, Australia |
| 11:15-11:45 |
Title: Challenges and Opportunities for Protein, Cell and Drug Delivery Engineering to Address Increasing Molecular Complexity in Biopharmaceuticals
Dr. David K. Robinson, Vice President of BioProcess R&D, Merck Research Laboratories, Merck & Co., Inc., USA |
|
11:45-13:00 |
Luncheon |
|
| ----------------------------------------------------------------------------------------------------------------------------------------------------- |
|
Time |
Track Sessions |
April 22, 2008
13:30-17:30
(Tuesday)
|
Session 1: Frontier of Emerging Human Proteome Technologies |
Session Chair: Dr. Yinghe Hu, Executive Director and Professor, Shanghai Institute of Brain Functional Genomics, East China Normal University, China
Co-Chair: Dr. Agasanur K. Prahalad, Scientist, Maine Institute for Genetics & Human Health, USA |
13:30-13:50 |
Title: Innovative Systems for Protein and Nucleic Acid Separation, Extraction & Analysis
Dr. Ilana Margalit, Chief Scientist, Ethrog Biotechnologies (Invitrogen Israel) Ltd., Israel |
13:50-14:10 |
Title: Comprehensive Proteomics Coverage Reveals Multipotent Nature of Ex Vivo Expanded
Adult Human Bone Marrow Derived Tissue Repair Cells
Dr. Agasanur K. Prahalad, Scientist, Maine Institute for Genetics & Human Health, USA |
14:10-14:30 |
Title: From High Throughput Protein Micro Chip toward Single Protein Molecule Array
Dr. Fan-Gang Tseng, Full Professor, National Tsing Hua University, Taiwan |
14:30-14:50 |
Title: Antibody Proteomics: Important Strategy for Filling the Gap between Gene Expression and Conventional Proteomics
Dr. Hisashi Koga, Senior Researcher, Kazusa DNA Research Institute, Japan |
14:50-15:10 |
Title: Disease Proteomics of High-Molecular-Mass Proteins (>100kDa) by Agarose 2-DE and
LC-MS/MS
Dr. Masamichi Oh-Ishi, Associate Professor, Kitasato University School of Science, Japan |
| 15:10-15:30 |
Tea Break |
15:30-15:50 |
Title: Detection of Proteins Based on Their Amino Acid Sequences
Dr. Yinghe Hu, Executive Director and Professor, Shanghai Institute of Brain Functional Genomics, East China Normal University, China |
15:50-16:10 |
Title: Fourier Transform Infrared Spectroscopy as a Tool for Rapid Determination of Protein Secondary Structure, Conformational Changes, and Aggregation
Dr. Silvia Maria Doglia, Associate Professor, University of Milano Bicocca, Italy |
16:10-16:30 |
Title: High-throughput Proteomic Techniques NAPPA Microarrays and Surface Plasmon Resonance (SPR) to Identify Kinase Substrates and Study Interactions
Dr. Sanjeeva Srivastava, Postdoctoral Fellow, Harvard Medical School, USA |
16:30-16:50 |
Title: A Proteomic Approach to the Identification of Molecular Targets Changed by L-Ascorbic Acid
Dr. Seyeon Park, Assistant Professor, Dongduk Women's University, Korea |
| 16:50-17:10 |
Title: Description of the Human Short ORFeome and Signaling Networks by Mass Spectrometry- based Proteomics
Dr. Masaaki Oyama, Assistant Professor, University of Tokyo, Japan |
| 17:10-17:30 |
Title: A High-throughput Technique for Identification of Ideal Folding Conditions for Regeneration of Therapeutically-relevant Proteins
Dr. Mahesh Narayan, Assistant Professor, University of Texas朎l Paso, USA |
|
April 23, 2008
8:30-12:00
(Wednesday)
|
Session 2: Breakthrough in Major Disease Proteomics and System Biology (Part Ⅰ) |
Session Chair: Dr. Roger W. Beuerman, Deputy/Scientific Director of Singapore Eye Research Institute, Singapore
Co-Chair: Dr. Lili Huang, Associate Director of Discovery Research, Dyax Corp, USA |
08:30-08:55 |
Title: Structural and Functional Analysis of Multiplly Post-translational Modified Proteins Related to Angiogenesis and Metastasis
Dr. Kong-Joo Lee, Professor, Ewha Womans University, Korea |
08:55-09:20 |
Title: Antibodies as Protease Inhibitors
Dr. Lili Huang, Associate Director of Discovery Research, Dyax Corp, USA |
09:20-09:45 |
Title: Selenium Binding Protein-1 in Chronic Allograft Rejection
Dr. Jose R. Torrealba, Assistant Professor, Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, USA |
09:45-10:10 |
Title: Protein Interaction Network Analysis of Vesicular Proteins via Comprehensive Proteomic Studies of Tumor-derived Membrane Vesicles: From Cellular Dusts to Nanocosmos
Dr. Yong Song Gho, Assistant Professor, Department of Life Science, Pohang University of Science and Technology, Korea |
| 10:10-10:20 |
Tea Break |
10:20-10:45 |
Title: Proteomics of Dry Eye Disease and a Diagnostic Biomarker Panel
Dr. Roger W. Beuerman, Deputy/Scientific Director of Singapore Eye Research Institute, Singapore |
10:45-11:10 |
Title: Discovering Pharmacodynamic Mechanisms of Drugs through Proteomic Approach
Dr. Roman Paskulin, Director of OMI, Institute for Anthropological Medicine, Slovenia |
11:10-11:35 |
Title: The Corepressor N-CoR Complex: Roles in Transcriptional Regulation and Cell Cycle
Dr. Jiemin Wong, Professor and Associate Director, The Institute of Biomedical Sciences, East China Normal University, China |
11:35-12:00 |
Title: Contraction of Inclusion Bodies and Its Implication in Biotechnology and Medicine
Dr. Spela Peternel, Research Assistant, National Institute of Chemistry, Slovenia |
|
April 23, 2008
13:30-17:20
(Wednesday)
|
Session 3: Bioinformatics and Structural Proteomics (Part Ⅰ) |
Session Chair: Dr. Pei Tang, Associate Professor, University of Pittsburgh School of Medicine, USA
Co-Chair: Dr. Morgan Giddings, Assistant Professor, University of North Carolina, USA |
13:30-14:00 |
Keynote Speech:
Title: TBD
Dr. David Sigfredo Angulo, Faculty, DePaul University, USA |
14:00-14:30 |
Title: Ecdysone Receptor Function and Structure
Dr. Ronald J. Hill, Chief Research Scientist, CSIRO Molecular and Health Technologies, Australia |
14:30-15:00 |
Title: Identifying Disordered Regions in Proteins by Limited Proteolysis
Dr. Angelo Fontana, Professor, CRIBI Biotechnology Centre, University of Padua, Italy |
15:00-15:30 |
Title: Proteogenomic Mapping for the Human Genome: Technologies and Challenges for Identifying Protein-Coding Sequences
Dr. Morgan Giddings, Assistant Professor, The University of North Carolina, USA |
15:30-15:50 |
Tea Break |
15:50-16:20 |
Title: Unorthodox Protein Structures of the Postgenomic Era
Dr. Istvan Simon, Scientific Advisor of Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Hungary |
16:20-16:50 |
Title: Structural and Dynamic View on Interactions of Low-Affinity Drugs with Neuronal
Acetylcholine Receptors
Dr. Pei Tang, Associate Professor, University of Pittsburgh School of Medicine, USA |
16:50-17:20 |
Title: Amyloid Peptide Nucleation Mechanism Explored by Global Optimization
Dr. Yuguang Mu, Assistant Professor, Nanyang Technological University, Singapore |
|
April 24, 2008
8:30-12:00
(Thursday)
|
Session 4: Breakthrough in Major Disease Proteomics and System Biology (Part Ⅱ) |
Session Chair: Dr. Xiaotao Li, Professor, Institute of Biomedical Sciences, East China Normal University, China
Co-Chair: Dr. Kin-Fu Chak, Professor, National Yang Ming University, Taiwan |
08:30-08:55 |
Keynote Speech:
Title: Selection of High Value Mammalian Cell Lines from Heterogeneous Populations for
Therapeutic Protein Production
Dr. Julian F Burke, Chief Scientific Officer, Genetix Limited, UK |
08:55-09:20 |
Title: Involvement of aFGF in the Repair Process of the Spinal Cord Injury Revealed by Proteomic Approach
Dr. Kin-Fu Chak, Professor, National Yang Ming University, Taiwan |
09:20-09:45 |
Title: Systems Biology to Unravel Signaling Networks in the Heart
Dr. Thomas M. Vondriska, Assistant Professor, University of California, USA |
09:45-10:10 |
Title: Structural Biology of Dementia
Dr. Michael Parker, Professor, St. Vincent' s Institute, Australia |
10:10-10:20 |
Tea Break |
10:20-10:45 |
Title: Towards the Identification of Novel Heart Failure Markers: the Role of Proteomics
Dr. Georg Hess, Medical Director, Roche Diagnostics GmbH, Germany |
10:45-11:10 |
Title: A Novel Proteasome Degradation Pathway Mediated by 11S Activator REGgamma and
Its Important Role in Human Diseases
Dr. Xiaotao Li, Professor, The Institute of Biomedical Sciences, East China Normal University, China |
11:10-11:35 |
Title: A Novel Immunoproteome: A System Handling Hydrophobic Portions of Biological Molecules
Dr. Seung-Yong Seong, Professor, Seoul National University College of Medicine, Korea |
11:35-12:00 |
Title: Rapid Detection of Peptide Hormones from Cultured Neuro/Endocrine Cells
Dr. Christina Buchanan, Research Fellow, Maurice Wilkins Centre for Molecular Biodiscovery, University of Auckland, New Zealand |
|
April 24, 2008
13:30-17:10
(Thursday)
|
Session 5: Protein/Peptide Structure Activity and Interaction (Part Ⅰ) |
Session Chair: Dr. Vettai Ananthanarayanan, Professor Emeritus of Biochemistry & Biomedical Sciences, McMaster University, Canada
Co-Chair: Dr. Micky Tortorella, Senior Principal Scientist, Pfizer Inc., USA |
13:30-13:50
|
Keynote Speech:
Title: High Resolution Crystal Structure of the Catalytic Domain of ADAMTS-5 (Aggrecanase-2)
Dr. Micky Tortorella, Senior Principal Scientist, Pfizer Inc., USA |
13:50-14:10 |
Title: Commonalities, Specificities, and Evolutionary Aspects in the Interaction of Scorpion Toxins with Voltage-gated Sodium Channels
Dr. Michael Gurevitz, Professor, Tel Aviv University, Israel |
14:10-14:30 |
Title: Molecular Signaling for the Regulation of Sperm Motility
Dr. Kazuo Inaba, Professor/Director, University of Tsukuba, Japan |
14:30-14:50 |
Title: Conformationally Restricted Deltorphin Analogs: Structure and Opioid Activity
Dr. Jerzy Ciarkowski, Full Professor of University of Gdansk, Poland |
14:50-15:10 |
Title: Evidence of a New Type of Protein-Protein Interaction between Gels of Different Compositions: Dependence on Volume/Volume Ratios and High Mobility of Minor Components
Dr. Vladimir Matveev, Professor, Institute of Cytology, Russian Academy of Sciences, Russia |
15:10-15:30 |
Tea Break |
15:30-15:50 |
Title: Heteroscorpine (HS) Toxin from Venom of Thai Giant Scorpion (Heterometrus sp.) with Antibacterial Activities
Dr. Sakda Daduang, Associate Professor, Khon Kaen University, Thailand |
15:50-16:10 |
Title: Twenty One Years since Chernobyl Disaster: What Seed Protein can Tell Us?
Dr. Martin Hajduch, Senior Scientist, Institute of Plant Genetics and Biotechnology, Slovak Academy of Sciences, Slovakia |
| 16:10-16:30 |
Title: Hsp47, a Collagen-specific Molecular Chaperone, as a Potential Drug Target
Dr. Vettai S. Ananthanarayanan, Professor Emeritus of Biochemistry & Biomedical Sciences, McMaster University, Canada |
| 16:30-16:50 |
Title: Kinetics of Intramolecular Contact Formation in Disordered Peptides and Unfolded Proteins
Dr. Marco Buscaglia, Researcher, University of Milan, Italy |
| 16:50-17:10 |
Title: Identification and Structure-Function Characterizations of Domains in the V(D)J Recombination Protein, RAG1
Dr. Karla K. Rodgers, Associate Professor, University of Oklahoma Health Sciences Center, USA |
|
|
Time |
Track Sessions |
April 22, 2008
13:30-15:30
(Tuesday) |
Session 6: Biomarkers in Early Drug Development |
Session Chair: Dr. Moulay Alaoui-Jamali, Full Professor, McGill University, Canada
Co-Chair: Dr. Jianbing Zhang, Research Officer, Institute for Biological Sciences, National Research
Council of Canada, Canada |
13:30-13:55 |
Keynote Speech:
Title: The Carbohydrate Polysialic (PSA) on NCAM, a Marker and an Actor of Cell Plasticity: Design of Mimetic Peptides to Modulate Its Function
Dr. Geneviève Rougon, Director of Institute of Developmental Biology of Marseille, France |
13:55-14:20 |
Title: Biomarker Discovery with Single Domain Antibody
Dr. Jianbing Zhang, Research Officer, Institute for Biological Sciences, National Research Council of Canada, Canada |
14:20-14:45 |
Title: Peptidomics: Challenges and Practical Perspectives
Dr. Vadim T. Ivanov, Professor, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry,
Russian Academy of Sciences, Russia |
14:45-15:10 |
Title: Biomarkers of Early Stage Breast Cancer Invasion: From Cell Signaling to Clinical Validation and Drug Discovery
Dr. Moulay Alaoui-Jamali, Full Professor of Oncology, McGill University, Canada |
15:10-15:30 |
Tea Break |
|
April 23, 2008
8:30-12:00
(Wednesday) |
Session 7: Biomarkers in Clinical Development |
Session Chair: Dr. Virginia M. Miller, Professor, Mayo Clinic College of Medicine, USA
Co-Chair: Dr. David J. Weber, Professor and Acting Chairman, University of Maryland School of Medicine, USA |
08:30-09:00 |
Title: Biomarkers in Diseases of the Lower Urinary Tract
Dr. Samuel K. Chacko, Professor, University of Pennsylvania, USA |
09:00-09:30 |
Title: Inhibiting the Calcium-binding Protein S100B Restores P53-dependent Apoptosis
Dr. David J. Weber, Professor and Acting Chairman, University of Maryland School of Medicine, USA |
09:30-10:00 |
Title: New Biomarkers for the Estimation of Cardiometabolic Risk
Dr. Damien Gruson, Unit of Diabetes and Nutrition, Cliniques Universitaires St Luc, Belgium |
10:00-10:30 |
Tea Break |
10:30-11:00 |
Title: Can Phenotypic Assessment of Blood Borne Microvesicles be Used as a Marker of Early Endothelial Dysfunction and Thrombotic Risk?
Dr. Virginia M. Miller, Professor, Mayo Clinic College of Medicine, USA |
11:00-11:30 |
Title: Dominant Negative Rac1 Attenuates Paclitaxel-Induced Apoptosis in Human Melanoma
Cells Through Upregulation of Heat Shock Protein 27: A Functional Proteomic Analysis
Dr. Shao Chin Lee, Principal Investigator/Scientist, National University of Singapore, Singapore |
11:30-12:00 |
Title: Proteomic Identification of Biomarkers of Heart Failure
Dr. Qin M. Chen, Associate Professor, Department of Pharmacology, University of Arizona College of Medicine, USA |
|
April 23, 2008
13:30-17:20
(Wednesday) |
Session 8: Biomarkers for Molecular Diagnostics and Analysis Technologies Development |
Session Chair: Dr. Hana Kovarova, Senior Scientist, Academy of Sciences of the Czech Republic, President of the Czech Proteomic Society, Czech Republic
Co-Chair: Dr. Weichuan Yu, Assistant Professor, Department of Electronic and Computer Engineering, Hong Kong University of Science and Technology, China |
13:30-14:00 |
Keynote Speech:
Title: Current Issues in Biomarker Discovery, Development and Commercialization
Dr. Thomas M. Li, Senior Director, Technology Mgmt., Chief Technology Officer, Roche
Diagnostics, USA |
14:00-14:25 |
Title: Novel 3D- flow-through Protein Biosensor for Rapid Clinical Diagnostics
Dr. Chamindie Punyadeera, Senior Scientist, Philips Research Laboratories, The Netherlands |
14:25-14:50 |
Title: High-throughput Identification of Clinical Pathogenic Fungi by Hybridization to an Oligonucleotide Microarray
Dr. Jun-Wen Li, Professor/Director, Institute of Environment and Health, Academy of Military Medical Sciences, China |
14:50-15:15 |
Title: Cancer Biomarker Discovery Using Mass Spectrometry Data
Dr. Weichuan Yu, Assistant Professor, Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, China |
15:15-15:40 |
Tea Break |
15:40-16:05 |
Title: Proteins and Signaling Pathways Driving Neural Stem Cell Differentiation
Dr. Hana Kovarova, Senior Scientist, Academy of Sciences of the Czech Republic, President of the Czech Proteomic Society, Czech Republic |
16:05-16:30 |
Title: Protein Chip Development: Application to the Detection of Autoantibodies in Human Serum
Dr. Emmanuelle Laurenceau, Assistant Professor, Lyon Nanotechnology Institute, Claude Bernard University, France |
| 16:30-16:55 |
Title: Protective or Detrimental Effect on Apoptosis Depends on the Pattern and Amount of Calcium Release: BAX inhibitor-1
Dr. Han-Jung Chae, Assistant Professor, Chonbuk National University, Korea |
| 16:55-17:20 |
Title: The Proteome and Discovery of Biomarkers in Health and Disease
Dr. Suresh Jivan Gadher, Senior Researcher, Institute of Animal Physiology and Genetics, Academy of Sciences of Czech Republic, Czech Republic |
|
|
Time |
Track Sessions |
April 24, 2008
8:30-12:00
(Thursday) |
Session 9: Peptide / Protein as Anti-Cancer Agents (Part Ⅰ) |
Session Chair: Dr. Shaun McColl, Professor, University of Adelaide, Australia
Co-Chair: Dr. Wande Li, Associate Research Professor, Department of Biochemistry Boston University School of Medicine, USA |
08:30-08:55 |
Keynote Speech:
Title: Learning from Nature: The Design and Development of Peptide-based Spectrum-specific
Therapeutic Vaccines
Dr. Niels P. Emmerich, Managing Director and Chief Operating Officer, Immatics Biotechnologies GmbH, Germany |
08:55-09:20 |
Title: MALDI-TOF-MS Discrimination of Extended-spectrum *-lactamase (ESBL) P roducing
Bacteria
Dr. Richard O Jenkins, Professor, De Montfort University, UK |
09:20-09:45 |
Title: Clinical Trials of Anti-mesothelin Antibodies for Cancer Therapy
Dr. Raffit Hassan, Chief, Solid Tumor Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, USA |
09:45-10:10 |
Title: Lysyl Oxidase Oxidizes and Inactivates Key Cell Mitogens, a Molecular Basis for Its Tumor Suppressor Activity
Dr. Wande Li, Associate Research Professor, Department of Biochemistry, Boston University,
School of Medicine, USA |
10:10-10:20 |
Tea Break |
10:20-10:45 |
Title: Differential Effects of CXCL12 and a CXCL12 Antagonist on Breast Cancer Growth and
Metastasis
Dr. Shaun McColl, Professor, University of Adelaide, Australia |
10:45-11:10 |
Title: Essential Role of the Self-Renewal Gene Nanog in Regulating Tumor Development
Dr. Dean G. Tang, Associate Professor, University of Texas M. D Anderson Cancer Center, USA |
11:10-11:35 |
Title: Design and Characterization of Peptides/Depsipeptides as Anticancer Agents
Dr. David Sept, Primary Professor, The Center for Computational Biology, Washington University in St. Louis, USA |
11:35-12:00 |
Title: Targeting PYK2 and Its Protein-protein Interactions in the Integrin Signaling Pathway for Anti-cancer Therapeutics Development
Dr. Rongbao Li, Leader, Protein Structural Biology, Southern Research Institute, USA |
|
April 22, 2008
15:30-17:10
(Tuesday) |
Session 10: From CADD to Booming Peptide Drug Development |
Session Chair: Dr. Ye Che, Senior Scientist, Pfizer Global Research and Development, USA
Co-Chair: Dr. Ib Jonassen, Senior Principal Scientist, Diabetes Protein Engineering, Novo Nordisk A/S, Denmark |
15:30-15:55 |
Keynote Speech:
Title: Chemical Engineering of Insulin by Acylation with Either Fatty Acids or Derivatives of Cholic Acid Results in Prolonged Action and Serum Albumin Binding
Dr. Ib Jonassen, Senior Principal Scientist, Diabetes Protein Engineering, Novo Nordisk A/S, Denmark |
15:55-16:20 |
Title: Validation and Integration of Protein 3D Structure Information
Dr. Haruki Nakamura, Head/Professor of Protein Data Bank Japan, Institute for Protein Research, Osaka University, Japan |
16:20-16:45 |
Title: Structure-Guided Transformation of Proteins into Small Molecule Leads
Dr. Ye Che, Senior Scientist, Pfizer Global Research and Development, USA |
16:45-17:10 |
Title: 'Silencing' a Cell Penetrating Peptide Using Hydropobhic Anchors
Dr. Dennis Lowik, Assistant Professor, Radboud University Nijmegen, The Netherlands |
|
April 22, 2008
13:30-17:10
(Tuesday) |
Session 11: Peptide / Protein as Anti-Cancer Agents (Part Ⅱ) |
Session Chair: Dr. Yuanpeng Janet Huang, Assistant Professor, Rutgers University, USA
Co-Chair: Dr. Shaolin Hong, Researcher, Duke University Medical Center, USA |
13:30-13:55 |
Keynote Speech:
Title: Lunasin, a Novel and Unique Cancer Preventive Seed Peptide that Inhibits Core Histone Acctylation and Retinoblastoma (Rb) Phosphorylation
Dr. Ben O. de Lumen, Professor, University of California Berkeley and Chairman of the Board, FilGen BioSciences, Inc., USA |
13:55-14:20 |
Title: ErbB Inhibitory Protein[EBIP]: A Modified Ectodomain of Human EGFR is a Potential
Anti-cancer Agent
Dr. Adhip P. N. Majumdar, Senior Research Scientist of VA Medical Center, Wayne State University, USA |
14:20-14:45 |
Title: Discovery of Protein Biomarkers to Predict Early Stage Non-small Cell Lung Cancer
Recurrence
Dr. Shaolin Hong, Researcher, Duke University Medical Center, USA |
14:45-15:10 |
Title: Progress in Development of Anti-cancer Drugs without Unwanted Side Effects
Dr. Judit Ovádi, Professor, Institute of Enzymology, Biological Research Center, Hungarian
Academy of Sciences, Hungary |
15:10-15:30 |
Tea Break |
| 15:30-15:55 |
Title: Peptide-targeted Chemotherapy and Diagnosis
Dr. Chin-Tarng Lin, Professor, National Taiwan Unverstiy, Taiwan |
15:55-16:20 |
Title: Targeting the Human Cancer Pathway Protein Interaction Network by Structural Genomics
Dr. Yuanpeng Janet Huang, Assistant Professor, Rutgers University, USA |
| 16:20-16:45 |
Title: Proteome Analysis of Human Solid Cancers Using Various Proteomic Approaches and Its Application for Diagnosis and Treatment of Cancer
Dr. Takeshi Tomonaga, Associate Professor, Graduate School of Medicine, Chiba University, Japan |
| 16:45-17:10 |
Title: Novel Sensitizers of TRAIL-induced Apoptosis
Dr. Shazib Pervaiz, Professor, Department of Physiology, National University of Singapore, Singapore |
|
April 23, 2008
8:30-10:20
(Wednesday) |
Session 12: Peptide / Protein as Anti-Infective Drugs |
Session Chair: Dr. Roger W. Beuerman, Deputy/Scientific Director of Singapore Eye Research Institute, Singapore
Co-Chair: Dr. David Swift Jessop, Senior Research Fellow, University of Bristol, UK |
08:30-08:55 |
Title: Prion Diseases and Emerging Prion Diseases
Dr. Takashi Yokoyama, Team Leader, Prion Disease Research Center, National Institute of Animal Health, Japan |
08:55-09:20 |
Title: Endomorphins in the Immune System: Distribution and Anti-inflammatory Functions
Dr. David Swift Jessop, Senior Research Fellow, University of Bristol, UK |
09:20-09:45 |
Title: Analogues of Human Defensins, hBD3, without Cytotoxicity to Human Epithelial Cells
and Their Anti-microbial Properties
Dr. Roger W. Beuerman, Deputy/Scientific Director of Singapore Eye Research Institute, Singapore |
09:45-10:10 |
Title: Insights into Protein Folding and Misfolding from Analytic and Computational Models: Applications to Prion Diseases and Familial ALS
Dr. Steven Samuel Plotkin, Assistant Professor, University of British Columbia, Canada |
10:10-10:20 |
Tea Break |
|
April 24, 2008
8:30-12:00
(Thursday) |
Session 13: Proteins/Peptides for CNS Diseases |
Session Chair: Dr. Maria Esther Cobe de Celis, Member of CONICET, Professor of Medical Sciences, UNC, Argentina
Co-Chair: Dr. Lian Li, Professor, Emory University School of Medicine, USA |
08:30-08:55 |
Title: Antidepressive Action of Urocortins: Possible Therapeutical Application
Dr. Gyula Telegdy, Emeritus Professor, Medical School University of Szeged, Hungary |
08:55-09:20 |
Title: Parkinson's Disease Proteins: Molecular Pathogenesis and Therapeutic Implications
Dr. Lian Li, Professor of Pharmacology, Emory University School of Medicine, USA |
09:20-09:45 |
Title: Alpha-lactalbumin as Safety Trypthophan Supplier in Neurological Diseases
Dr. Paolo Mainardi, Professor, Opthalmology and Genetic, University of Genova, Italy |
09:45-10:10 |
Title: Modulation of Post-ischemia Vimentin and Nestin Expression in the Brain by Umbilical-cord Matrix Stem Cell Pretreatment
Dr. Yan Xu, Vice-Chair, Department of Anesthesiology, University of Pittsburgh School of
Medicine, USA |
10:10-10:30 |
Tea Break |
10:30-11:00 |
Title: A Possible Function of Neuropeptide EI (NEI)
Dr. Maria Esther Cobe de Celis, Member of CONICET, Professor of Medical Sciences, UNC, Argentina |
11:00-11:30 |
Title: An Expedition of Drug Discovery for Neurological Condition: Insulin-like Growth Factor (IGF) -1 and Its Analogues
Dr. Jian Guan, Senior Research Fellow, The Liggins Institute, The University of Auckland, New Zealand |
| 11:30-12:00 |
Title: Albumin Synthesis in Brain: Implications for Alzheimer's Disease
Dr. Bonghee Lee, Director, Institute for Systems Medicine, Lee Gil Ya Cancer and Diabetes
Institute, Gachon University of Medicine and Science, Korea |
|
April 24, 2008
13:30-17:30
(Thursday) |
Session 14: Proteins/Peptides for Cardiovascular & Cerebrovascular Disease |
Session Chair: Dr. Eunice C. Y. Li-Chan, Professor, Food, Nutrition & Health (FNH), University of British Columbia, Canada
Co-Chair: Dr. Simon J. T. Mao, Dean, Department of Biological Science and Technology, National Chiao Tung University, Taiwan |
13:30-14:05 |
Title: Peptides and Glial Regulation of Pain
Dr. Elisabeth Hansson, Professor in Neurobiology, The Sahlgrenska Academy at Gteborg University, Sweden |
14:05-14:40 |
Title: Lipid Dependant Disorder-to-order Conformational Transitions in Apolipoprotein CI Derived Peptides
Dr. Jaime Mas Oliva, Professor, Institute of Cellular Physiology, National Autonomous University of Mexico, Mexico |
14:40-15:25 |
Title: Plasma Haptoglobin Phenotype 1-1 is a Risk Factor for Coronary Heart Disease
Dr. Simon J. T. Mao, Dean, Department of Biological Science and Technology, National Chiao
Tung University, Taiwan |
15:25-15:40 |
Tea Break |
15:40-16:15 |
Title: Food Protein Hydrolysates and Peptides with Angiotensin-I Converting Enzyme Inhibitory Activity
Dr. Eunice C. Y. Li-Chan, Professor, Food, Nutrition & Health (FNH), The University of British Columbia, Canada |
16:15-16:55 |
Title: Heme Oxygenase-1 as Therapeutic Target on Hemorrhagic Shock-induced Oxidative Tissue Injuries
Dr. Toru Takahashi, Senior Assistant Professor, Okayama University Medical School, Japan |
16:55-17:30 |
Title: Angiogenic Peptides and Ischemic Diseases
Dr. Jonghoe Byun, Assistant Professor, Dankook University, Korea |
|
April 24, 2008
13:30-17:10
(Thursday) |
Session 15: Nanomaterials, Peptide / Protein Drug Delivery Technology |
Session Chair: Dr. Wei Wang, Associate Research Fellow, Pfizer Inc., USA
Co-Chair: Dr. Qiqing Zhang, Professor, Institute of Biomedical Engineering (IBME), Chinese Academy of Medical Sciences, China |
13:30-13:55 |
Title: Targeting a Protein Drug by Magnetic Nanoparticles
Dr. Shyh-Yu Shaw, Chairman of Institute of Biotechnology, National Cheng Kung University, Taiwan |
13:55-14:20 |
Title: More and More Human and Animal Coronaviruses: Comparative Genome Analysis Facilitates Discovery of Potential Novel Drug Targets
Dr. Patrick Woo, Professor, The University of Hong Kong, China |
| 14:20-14:45 |
Title: A Novel Functionalized Injectable Hydrogel for Long Term Delivery of Protein
Dr. Doo Sung Lee, Professor, Sung Kyun Kwan University, Korea |
14:45-15:10 |
Title: Self-aggregated Nanoparticles of Cholesterol-modified O-carboxymethyl Chitosan Conjugates and Its Interaction with Bovine Serum Albumin
Dr. Qiqing Zhang, Professor, Institute of Biomedical Engineering (IBME), Chinese Academy of Medical Sciences, China |
15:10-15:30 |
Tea Break |
15:30-15:55 |
Title: Overcoming Stability Challenges in Peptide/Protein Drug Delivery
Dr. Wei Wang, Associate Research Fellow, Pfizer Inc., USA |
15:55-16:20 |
Title: Cellular Delivery of Engineered Macromolecular Nanocomplexes for Gene and Protein
Therapy
Dr. Esther Vazquez, Associated Professor of IBB, University Autonoma of Barcelone, Spain |
| 16:20-16:45 |
Title: Novel Transcription Factor-like Function of Human Matrix Metalloproteinase-3 (MMP3)
Regulating CCN Protein 2/Connective Tissue Growth Factor (CCN2/CTGF) Gene: Possible Role of Dual-Functioning MMP3 in Matrix Remodeling
Dr. Masaharu Takigawa, Dean of Okayama University Dental School, Japan |
16:45-17:10 |
Title: Site-specific PEGylation of Pharmaceutical Proteins Mediated by Transglutaminase
Dr. Francesco M. Veronese, Professor, Department of Pharmaceutical Sciences, University of Padua, Italy |
|
|
Time |
Track Sessions |
April 23, 2008
13:30-16:30
(Tuesday) |
Session 16: Protein and Peptide Vaccine Research and Development |
Session Chair: Dr. Geert-Jan Boons, Professor, Complex Carbohydrate Research Center, University of Georgia, USA
Co-Chair: Dr. Markus Ollert, Professor/Vice-Chairman, Department of Dermatology and Allergy, Technology University Munich (TUM), Germany |
13:30-14:10 |
Title: Chimeric Antibodies: Addressing Current Challenges of Immunoassay Performance
Dr. Markus Ollert, Professor/Vice-Chairman, Department of Dermatology and Allergy, Technology University Munich (TUM), Germany |
14:10-14:50 |
Title: MHC-peptide Binding and in Silico Prediction
Dr. Tong Joo Chuan, Principal Investigator, Institute for Infocomm Research, Singapore |
14:50-15:30 |
Title: Investigating the Role of Antigen Structure and Dynamics in Complement-mediated
Bactericidity
Dr. Xavier Daura, Associate Professor, ICREA and Universitat Autonoma de Barcelona, Spain |
15:30-15:50 |
Tea Break |
| 15:50-16:30 |
Title: Towards a Fully Synthetic Three-component Carbohydrate-based Cancer Vaccine
Dr. Geert-Jan Boons, Professor, Complex Carbohydrate Research Center, University Of Georgia, USA |
|
April 23, 2008
8:30-12:00
(Wednesday) |
Session 17: Outsourcing Antibody Development and Production |
Session Chair: Dr. Jim Mo, Research Fellow, Pfizer Inc., USA
Co-Chair: Dr. Amy H. Que, Scientist, Oceanside Process Research & Development, Genentech, Inc., USA |
08:30-08:50 |
Title: Speedy Generation of Antibodies for Proteomics & Biomarker Discovery
Dr. Le Sun, President & CEO, AbMax Biotechnology Co, Ltd., China |
08:50-09:15 |
Title: Sequence Variant Analysis for Clone Selection in Monoclonal Antibody Process Development: A Case Study
Dr. Amy H. Que, Scientist, Oceanside Process Research & Development, Genentech, Inc., USA |
09:15-09:40 |
Title: The Next Generation of Novel Monoclonal Antibodies by B-Cell Targeting
Dr. Masahiro Tomita, Professor, Graduate School of Engineering, Mie University, Japan |
09:40-10:05 |
Title: Perspectives of Catalytic Antibodies Targeting Crucial Antigens Relating to the Cause of Infectious Diseases
Dr. Taizo Uda, Professor of Applied Chemistry, Oita University, Japan |
10:05-10:20 |
Tea Break |
10:20-10:45 |
Title: Shortening the Distance from Research to Clinical Production
Dr. Hans J Johansson, Senior Scientist, GE Healtcare, Sweden |
10:45-11:10 |
Title: Separation and Quantification of Product-Related Variants and Impurities in Monoclonal Antibodies
Dr. Jim Mo, Research Fellow, Pfizer Inc., USA |
11:10-11:35 |
Title: A Novel Human Antibody Inducing Autophagic Cell Death in a Variety of Cancer Cells
Dr. Yong-Sung Kim, Assistant Professor, Ajou University, Korea |
11:35-12:00 |
Title: Ultra-high Field NMR and Sugar Library Approaches for Structural Glycomics
Dr. Koichi Kato, Professor, Institute for Molecular Science & Nagoya City University, Japan |
|
April 22, 2008
13:30-17:30
(Tuesday) |
Session 18: Protein/Peptide Structure Activity and Interaction (Part Ⅱ) |
Session Chair: Dr. William Rodgers, Assistant Member, Oklahoma Medical Research Foundation, USA
Co-Chair: Dr. Jeff X. Zhu, Principal Scientist, Pfizer Global R& D, San Diego, USA |
13:30-13:55 |
Keynote Speech:
Title: Label-Free, Surface Plasmon Resonance Based Interaction Analysis: An Indispe | | | | |
